March 24, 2021

PPD and Clinical Ink Collaborate on Innovative Process for Lupus Assessment and Near Real-Time Access to Endpoint Data

WILMINGTON, N.C.–(BUSINESS WIRE)–PPD and Clinical Ink have developed a systemic lupus erythematosus (SLE) assessment review process to simplify clinical trials for the chronic disease


Leave Comment


Your Name *
Your Email *
Your Website
Comment *